Center-Authored Papers

Filters: Author is Reardon, David A  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
C
Chamberlain MC, Cloughsey T, Reardon DA, Wen PY.  2012.  A novel treatment for glioblastoma: integrin inhibition.. Expert review of neurotherapeutics. 12(4):421-35. Abstract
N
Nayak L, DeAngelis LM, Brandes AA, Peereboom DM, Galanis E, Lin NU, Soffietti R, Macdonald DR, Chamberlain M, Perry J et al..  2017.  The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.. Neuro-oncology. 19(5):625-635. Abstract
S
Schiff D, Desjardins A, Cloughesy T, Mikkelsen T, Glantz M, Chamberlain MC, Reardon DA, Wen PY.  2015.  Phase 1 dose escalation trial of the safety and pharmacokinetics of cabozantinib concurrent with temozolomide and radiotherapy or temozolomide after radiotherapy in newly diagnosed patients with high-grade gliomas.. Cancer. Abstract
W
Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen GA, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB et al..  2010.  Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 28(11):1963-72. Abstract